Pharmafile Logo
Pharmafocus logo
Advanced Search

influenza

Showing 12 posts of 42 posts found.

flu_vaccine

‘Universal flu vaccine’ to be trialed this winter

October 3, 2017
Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …

News
child_flu

Collaboration brings forward potential broad flu cure

October 2, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical

A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …

News
diabetes-776999_960_720

Swine flu pandemic linked to increased incidence of diabetes

September 19, 2017
Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu

The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …

News
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017
Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …

News
15813-a-senior-woman-receiving-a-vaccination-shot-from-her-doctor-pv

Influenza vaccine market to grow to £4.3 billion by 2025

October 31, 2016
Sales and Marketing influenza

GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion …

News
sanofi_pasteur_scientist

MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use

July 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi pasteur msd, UK, Vaccine, flu, influenza

Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: …

News
needles

CSL’s flu vaccine scores FDA approval

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus

Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …

News
flu vaccine

Sanofi Pasteur ‘actively exploring’ universal flu vaccine

November 10, 2015
Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine

Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …

News
vaccine image

China flu vaccine gets WHO seal of approval

June 12, 2015
Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza

A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …

News

Novartis back under microscope

June 23, 2014
Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …

News
GlaxoSmithKline’s H1N1 vaccine Pandemrix

Doctors use GSK’s Pandemrix as seasonal flu vaccines fall short

January 10, 2011
Sales and Marketing GSK, GlaxoSmithKline, Pandemrix, flu, h1n1, influenza, vaccines

Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …

News

Flu ad campaign dusted off as cases rise

January 5, 2011
Medical Communications NHS, UK, disease awareness, flu, influenza

The Department of Health this week relaunched its advertising campaign to remind people of the importance of good hand and …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023